Tag Archives: reimbursment

Medicare Part B: Barriers to Cancer Treatment

Davenport-Ennis

The National Patient Advocate Foundation (PAF) has seen a notable rise in calls for assistance from both Medicare beneficiaries and cancer doctors regarding difficulty accessing certain cancer drugs in the physician office setting, where most patients receive their care. As a result, patients are being forced to seek cancer treatment in the hospital setting to access their life-saving cancer medicines; this displacement disrupts their continuum of care, is inconvenient, and is more costly to the Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Reimbursement Cuts Jeopardize Public Health

Bill Bro Headshot

Just this month physicians who administer lifesaving therapies in their offices are seeing their reimbursements cut due to the sequestration.  That’s because while some government spending was exempted from the sequestration, reimbursements under Medicare Part B were not. And yet, some continue to call for additional cuts to this important program, where some of the sickest patients receive their therapies under the administration of a physician.  Additional cuts to Medicare Part B would have a Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

We Are BIO

Jim Greenwood

Here’s what the Biotechnology Industry Organization is doing for you. This year, we challenged you to answer the question – What’s Your BIO? On behalf of the Biotechnology Industry Organization (BIO), I’d like to answer that question to illustrate how we advocate for federal, state and global policies to foster continued biotech breakthroughs, innovation and ingenuity. In addition to producing the BIO International Convention, we educate and engage public policy leaders in Washington, in state Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

Biotechnology and the State of the Union Address

The following was published in Politico’s Join the Debate.  Politico asked “What should Obama say in the State of the Union?”   Jim Greenwood Former Congressman (R-Pa.), President and CEO, Biotechnology Industry Organization :   The president’s State of the Union should, rightly, focus on jobs, particularly the need to create and fill new jobs to compete in an increasing competitive global marketplace. There’s no industry that better exemplifies the promise of job creation than Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,